HEADER HYDROLASE/HYDROLASE INHIBITOR 19-DEC-06 2OBO
TITLE STRUCTURE OF HEPATITIS C VIRAL NS3 PROTEASE DOMAIN COMPLEXED WITH NS4A
TITLE 2 PEPTIDE AND KETOAMIDE SCH476776
COMPND MOL_ID: 1;
COMPND 2 MOLECULE: HCV NS3 PROTEASE;
COMPND 3 CHAIN: A, C;
COMPND 4 FRAGMENT: UNP RESIDUES 1027 1207;
COMPND 5 ENGINEERED: YES;
COMPND 6 MOL_ID: 2;
COMPND 7 MOLECULE: HCV NS4A PEPTIDE;
COMPND 8 CHAIN: B, D;
COMPND 9 FRAGMENT: UNP RESIDUES 1678 1696;
COMPND 10 ENGINEERED: YES;
COMPND 11 MUTATION: YES
SOURCE MOL_ID: 1;
SOURCE 2 ORGANISM_SCIENTIFIC: HEPATITIS C VIRUS;
SOURCE 3 ORGANISM_TAXID: 11103;
SOURCE 4 GENE: HCV;
SOURCE 5 EXPRESSION_SYSTEM: ESCHERICHIA COLI;
SOURCE 6 EXPRESSION_SYSTEM_TAXID: 562;
SOURCE 7 MOL_ID: 2;
SOURCE 8 SYNTHETIC: YES;
SOURCE 9 ORGANISM_SCIENTIFIC: HEPATITIS C VIRUS;
SOURCE 10 ORGANISM_TAXID: 31647
KEYWDS KETOAMIDE INHIBITOR, VIRAL PROTEIN, HYDROLASE-HYDROLASE INHIBITOR
KEYWDS 2 COMPLEX
EXPDTA X-RAY DIFFRACTION
AUTHOR A.J.PRONGAY,Z.GUO,N.YAO,T.FISCHMANN,C.STRICKLAND,J.MYERS JR.,
AUTHOR 2 P.C.WEBER,B.MALCOLM,B.M.BEYER,R.INGRAM,J.PICHARDO,Z.HONG,
AUTHOR 3 W.W.PROSISE,L.RAMANATHAN,S.S.TAREMI,T.YAROSH-TOMAINE,R.ZHANG,
AUTHOR 4 M.SENIOR,R.YANG,A.ARASAPPAN,F.BENNETT,S.F.BOGEN,K.CHEN,E.JAO,Y.LIU,
AUTHOR 5 R.G.LOVE,A.K.SAKSENA,S.VENKATRAMAN,V.GIRIJAVALLABHAN,F.G.NJOROGE,
AUTHOR 6 V.MADISON
REVDAT 6 30-AUG-23 2OBO 1 REMARK SEQADV LINK
REVDAT 5 26-DEC-12 2OBO 1 COMPND DBREF REMARK SEQADV
REVDAT 5 2 1 SOURCE TITLE
REVDAT 4 22-FEB-12 2OBO 1 AUTHOR REMARK
REVDAT 3 13-JUL-11 2OBO 1 VERSN
REVDAT 2 24-FEB-09 2OBO 1 VERSN
REVDAT 1 31-JUL-07 2OBO 0
JRNL AUTH A.J.PRONGAY,Z.GUO,N.YAO,J.PICHARDO,T.FISCHMANN,C.STRICKLAND,
JRNL AUTH 2 J.MYERS JR.,P.C.WEBER,B.M.BEYER,R.INGRAM,Z.HONG,W.W.PROSISE,
JRNL AUTH 3 L.RAMANATHAN,S.S.TAREMI,T.YAROSH-TOMAINE,R.ZHANG,M.SENIOR,
JRNL AUTH 4 R.S.YANG,B.MALCOLM,A.ARASAPPAN,F.BENNETT,S.L.BOGEN,K.CHEN,
JRNL AUTH 5 E.JAO,Y.T.LIU,R.G.LOVEY,A.K.SAKSENA,S.VENKATRAMAN,
JRNL AUTH 6 V.GIRIJAVALLABHAN,F.G.NJOROGE,V.MADISON
JRNL TITL DISCOVERY OF THE HCV NS3/4A PROTEASE INHIBITOR
JRNL TITL 2 (1R,5S)-N-[3-AMINO-1-(CYCLOBUTYLMETHYL)-2,3-DIOXOPROPYL]-3-
JRNL TITL 3 [2(S)-[[[(1,1-DIMETHYLETHYL)AMINO]CARBONYL]AMINO]-3,
JRNL TITL 4 3-DIMETHYL-1-OXOBUTYL]-
JRNL TITL 5 6,6-DIMETHYL-3-AZABICYCLO[3.1.0]HEXAN-2(S)-CARBOXAMIDE (SCH
JRNL TITL 6 503034) II. KEY STEPS IN STRUCTURE-BASED OPTIMIZATION.
JRNL REF J.MED.CHEM. V. 50 2310 2007
JRNL REFN ISSN 0022-2623
JRNL PMID 17444623
JRNL DOI 10.1021/JM060173K
REMARK 1
REMARK 1 REFERENCE 1
REMARK 1 AUTH J.L.KIM,K.A.MORGENSTERN,C.LIN,T.FOX,M.D.DWYER,J.A.LANDRO,
REMARK 1 AUTH 2 S.P.CHAMBERS,W.MARKLAND,C.A.LEPRE,E.T.O'MALLEY,S.L.HARBESON,
REMARK 1 AUTH 3 C.M.RICE,M.A.MURCKO,P.R.CARON,J.A.THOMSON
REMARK 1 TITL CRYSTAL STRUCTURE OF THE HEPATITIS C VIRUS NS3 PROTEASE
REMARK 1 TITL 2 DOMAIN COMPLEXED WITH A SYNTHETIC NS4A COFACTOR PEPTIDE.
REMARK 1 REF CELL(CAMBRIDGE,MASS.) V. 87 343 1996
REMARK 1 REFN ISSN 0092-8674
REMARK 1 PMID 8861917
REMARK 1 DOI 10.1016/S0092-8674(00)81351-3
REMARK 1 REFERENCE 2
REMARK 1 AUTH A.ARASAPPAN,F.G.NJOROGE,T.Y.CHAN,F.BENNETT,S.L.BOGEN,K.CHEN,
REMARK 1 AUTH 2 H.GU,L.HONG,E.JAO,Y.T.LIU,R.G.LOVEY,T.PAREKH,R.E.PIKE,
REMARK 1 AUTH 3 P.PINTO,B.SANTHANAM,S.VENKATRAMAN,H.VACCARO,H.WANG,X.YANG,
REMARK 1 AUTH 4 Z.ZHU,B.MCKITTRICK,A.K.SAKSENA,V.GIRIJAVALLABHAN,J.PICHARDO,
REMARK 1 AUTH 5 N.BUTKIEWICZ,R.INGRAM,B.MALCOLM,A.PRONGAY,N.YAO,B.MARTEN,
REMARK 1 AUTH 6 V.MADISON,S.KEMP,O.LEVY,M.LIM-WILBY,S.TAMURA,A.K.GANGULY
REMARK 1 TITL HEPATITIS C VIRUS NS3-4A SERINE PROTEASE INHIBITORS: SAR OF
REMARK 1 TITL 2 P'2 MOIETY WITH IMPROVED POTENCY.
REMARK 1 REF BIOORG.MED.CHEM.LETT. V. 15 4180 2005
REMARK 1 REFN ISSN 0960-894X
REMARK 1 PMID 16087332
REMARK 1 DOI 10.1016/J.BMCL.2005.06.091
REMARK 1 REFERENCE 3
REMARK 1 AUTH K.X.CHEN,F.G.NJOROGE,A.PRONGAY,J.PICHARDO,V.MADISON,
REMARK 1 AUTH 2 V.GIRIJAVALLABHAN
REMARK 1 TITL SYNTHESIS AND BIOLOGICAL ACTIVITY OF MACROCYCLIC INHIBITORS
REMARK 1 TITL 2 OF HEPATITIS C VIRUS (HCV) NS3 PROTEASE.
REMARK 1 REF BIOORG.MED.CHEM.LETT. V. 15 4475 2005
REMARK 1 REFN ISSN 0960-894X
REMARK 1 PMID 16112859
REMARK 1 DOI 10.1016/J.BMCL.2005.07.033
REMARK 1 REFERENCE 4
REMARK 1 AUTH S.BOGEN,A.K.SAKSENA,A.ARASAPPAN,H.GU,F.G.NJOROGE,
REMARK 1 AUTH 2 V.GIRIJAVALLABHAN,J.PICHARDO,N.BUTKIEWICZ,A.PRONGAY,
REMARK 1 AUTH 3 V.MADISON
REMARK 1 TITL HEPATITIS C VIRUS NS3-4A SERINE PROTEASE INHIBITORS: USE OF
REMARK 1 TITL 2 A P2-P1 CYCLOPROPYL ALANINE COMBINATION FOR IMPROVED
REMARK 1 TITL 3 POTENCY.
REMARK 1 REF BIOORG.MED.CHEM.LETT. V. 15 4515 2005
REMARK 1 REFN ISSN 0960-894X
REMARK 1 PMID 16112862
REMARK 1 DOI 10.1016/J.BMCL.2005.07.009
REMARK 1 REFERENCE 5
REMARK 1 AUTH M.YI,X.TONG,A.SKELTON,R.CHASE,T.CHEN,A.PRONGAY,S.L.BOGEN,
REMARK 1 AUTH 2 A.K.SAKSENA,F.G.NJOROGE,R.L.VESELENAK,R.B.PYLES,N.BOURNE,
REMARK 1 AUTH 3 B.A.MALCOLM,S.M.LEMON
REMARK 1 TITL MUTATIONS CONFERRING RESISTANCE TO SCH6, A NOVEL HEPATITIS C
REMARK 1 TITL 2 VIRUS NS3/4A PROTEASE INHIBITOR. REDUCED RNA REPLICATION
REMARK 1 TITL 3 FITNESS AND PARTIAL RESCUE BY SECOND-SITE MUTATIONS.
REMARK 1 REF J.BIOL.CHEM. V. 281 8205 2006
REMARK 1 REFN ISSN 0021-9258
REMARK 1 PMID 16352601
REMARK 1 DOI 10.1074/JBC.M510246200
REMARK 2
REMARK 2 RESOLUTION. 2.60 ANGSTROMS.
REMARK 3
REMARK 3 REFINEMENT.
REMARK 3 PROGRAM : X-PLOR 98.1
REMARK 3 AUTHORS : BRUNGER
REMARK 3
REMARK 3 DATA USED IN REFINEMENT.
REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.60
REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 8.00
REMARK 3 DATA CUTOFF (SIGMA(F)) : NULL
REMARK 3 DATA CUTOFF HIGH (ABS(F)) : NULL
REMARK 3 DATA CUTOFF LOW (ABS(F)) : NULL
REMARK 3 COMPLETENESS (WORKING+TEST) (%) : NULL
REMARK 3 NUMBER OF REFLECTIONS : 14291
REMARK 3
REMARK 3 FIT TO DATA USED IN REFINEMENT.
REMARK 3 CROSS-VALIDATION METHOD : NULL
REMARK 3 FREE R VALUE TEST SET SELECTION : NULL
REMARK 3 R VALUE (WORKING SET) : 0.178
REMARK 3 FREE R VALUE : 0.295
REMARK 3 FREE R VALUE TEST SET SIZE (%) : NULL
REMARK 3 FREE R VALUE TEST SET COUNT : 1393
REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL
REMARK 3
REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN.
REMARK 3 TOTAL NUMBER OF BINS USED : NULL
REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.60
REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.71
REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 78.20
REMARK 3 REFLECTIONS IN BIN (WORKING SET) : NULL
REMARK 3 BIN R VALUE (WORKING SET) : 0.4102
REMARK 3 BIN FREE R VALUE : 0.2807
REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : NULL
REMARK 3 BIN FREE R VALUE TEST SET COUNT : 104
REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : NULL
REMARK 3
REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT.
REMARK 3 PROTEIN ATOMS : 2758
REMARK 3 NUCLEIC ACID ATOMS : 0
REMARK 3 HETEROGEN ATOMS : 42
REMARK 3 SOLVENT ATOMS : 135
REMARK 3
REMARK 3 B VALUES.
REMARK 3 FROM WILSON PLOT (A**2) : 28.00
REMARK 3 MEAN B VALUE (OVERALL, A**2) : NULL
REMARK 3 OVERALL ANISOTROPIC B VALUE.
REMARK 3 B11 (A**2) : NULL
REMARK 3 B22 (A**2) : NULL
REMARK 3 B33 (A**2) : NULL
REMARK 3 B12 (A**2) : NULL
REMARK 3 B13 (A**2) : NULL
REMARK 3 B23 (A**2) : NULL
REMARK 3
REMARK 3 ESTIMATED COORDINATE ERROR.
REMARK 3 ESD FROM LUZZATI PLOT (A) : NULL
REMARK 3 ESD FROM SIGMAA (A) : NULL
REMARK 3 LOW RESOLUTION CUTOFF (A) : NULL
REMARK 3
REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR.
REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : NULL
REMARK 3 ESD FROM C-V SIGMAA (A) : NULL
REMARK 3
REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES.
REMARK 3 BOND LENGTHS (A) : 0.008
REMARK 3 BOND ANGLES (DEGREES) : 1.937
REMARK 3 DIHEDRAL ANGLES (DEGREES) : NULL
REMARK 3 IMPROPER ANGLES (DEGREES) : 1.497
REMARK 3
REMARK 3 ISOTROPIC THERMAL MODEL : NULL
REMARK 3
REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA
REMARK 3 MAIN-CHAIN BOND (A**2) : NULL ; NULL
REMARK 3 MAIN-CHAIN ANGLE (A**2) : NULL ; NULL
REMARK 3 SIDE-CHAIN BOND (A**2) : NULL ; NULL
REMARK 3 SIDE-CHAIN ANGLE (A**2) : NULL ; NULL
REMARK 3
REMARK 3 NCS MODEL : NULL
REMARK 3
REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT
REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL
REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL
REMARK 3
REMARK 3 PARAMETER FILE 1 : NULL
REMARK 3 TOPOLOGY FILE 1 : NULL
REMARK 3
REMARK 3 OTHER REFINEMENT REMARKS: NULL
REMARK 4
REMARK 4 2OBO COMPLIES WITH FORMAT V. 3.30, 13-JUL-11
REMARK 100
REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 08-JAN-07.
REMARK 100 THE DEPOSITION ID IS D_1000040933.
REMARK 200
REMARK 200 EXPERIMENTAL DETAILS
REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION
REMARK 200 DATE OF DATA COLLECTION : NULL
REMARK 200 TEMPERATURE (KELVIN) : 95
REMARK 200 PH : NULL
REMARK 200 NUMBER OF CRYSTALS USED : 1
REMARK 200
REMARK 200 SYNCHROTRON (Y/N) : Y
REMARK 200 RADIATION SOURCE : APS
REMARK 200 BEAMLINE : 17-ID
REMARK 200 X-RAY GENERATOR MODEL : NULL
REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M
REMARK 200 WAVELENGTH OR RANGE (A) : 1.0
REMARK 200 MONOCHROMATOR : NULL
REMARK 200 OPTICS : NULL
REMARK 200
REMARK 200 DETECTOR TYPE : CCD
REMARK 200 DETECTOR MANUFACTURER : ADSC QUANTUM 210
REMARK 200 INTENSITY-INTEGRATION SOFTWARE : HKL-2000
REMARK 200 DATA SCALING SOFTWARE : SCALEPACK
REMARK 200
REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 22055
REMARK 200 RESOLUTION RANGE HIGH (A) : 2.600
REMARK 200 RESOLUTION RANGE LOW (A) : 50.000
REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 3.000
REMARK 200
REMARK 200 OVERALL.
REMARK 200 COMPLETENESS FOR RANGE (%) : 99.0
REMARK 200 DATA REDUNDANCY : 2.200
REMARK 200 R MERGE (I) : NULL
REMARK 200 R SYM (I) : 0.06900
REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : NULL
REMARK 200
REMARK 200 IN THE HIGHEST RESOLUTION SHELL.
REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.60
REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.66
REMARK 200 COMPLETENESS FOR SHELL (%) : 99.3
REMARK 200 DATA REDUNDANCY IN SHELL : 2.20
REMARK 200 R MERGE FOR SHELL (I) : NULL
REMARK 200 R SYM FOR SHELL (I) : 0.46600
REMARK 200 <I/SIGMA(I)> FOR SHELL : 2.200
REMARK 200
REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH
REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: FOURIER SYNTHESIS
REMARK 200 SOFTWARE USED: X-PLOR
REMARK 200 STARTING MODEL: PDB ENTRY 2O8M
REMARK 200
REMARK 200 REMARK: NULL
REMARK 280
REMARK 280 CRYSTAL
REMARK 280 SOLVENT CONTENT, VS (%): 68.04
REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 3.85
REMARK 280
REMARK 280 CRYSTALLIZATION CONDITIONS: THE PROTEIN (NS3 COMPLEXED WITH KK
REMARK 280 -NS4A(21-39)-KK PEPTIDE) WAS AT 12-15 MG/ML IN 15 MM MES, PH 6.5
REMARK 280 1 M NACL 20 MM B-MERCAPTOETHANOL. HANGING DROPS WERE FORMED BY
REMARK 280 MIXING 4:L PROTEIN SOLUTION WITH 4:L {0.75-1.0 M NACL, 0.1M NA/K
REMARK 280 PHOSPHATE 0.1 M MES, PH 5.8-6.1 20 MM B-MERCAPTOETHANOL} THE
REMARK 280 DROP WAS EQUILIBRATED THE DROPS OVER 1 ML {(1.25-1.50 M) NACL -
REMARK 280 0.1M NA/K PHOSPHATE 0.1 M MES, PH 5.6-5.8, 20 MM B-
REMARK 280 MERCAPTOETHANOL} , VAPOR DIFFUSION, HANGING DROP, TEMPERATURE
REMARK 280 277K
REMARK 290
REMARK 290 CRYSTALLOGRAPHIC SYMMETRY
REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: H 3 2
REMARK 290
REMARK 290 SYMOP SYMMETRY
REMARK 290 NNNMMM OPERATOR
REMARK 290 1555 X,Y,Z
REMARK 290 2555 -Y,X-Y,Z
REMARK 290 3555 -X+Y,-X,Z
REMARK 290 4555 Y,X,-Z
REMARK 290 5555 X-Y,-Y,-Z
REMARK 290 6555 -X,-X+Y,-Z
REMARK 290 7555 X+2/3,Y+1/3,Z+1/3
REMARK 290 8555 -Y+2/3,X-Y+1/3,Z+1/3
REMARK 290 9555 -X+Y+2/3,-X+1/3,Z+1/3
REMARK 290 10555 Y+2/3,X+1/3,-Z+1/3
REMARK 290 11555 X-Y+2/3,-Y+1/3,-Z+1/3
REMARK 290 12555 -X+2/3,-X+Y+1/3,-Z+1/3
REMARK 290 13555 X+1/3,Y+2/3,Z+2/3
REMARK 290 14555 -Y+1/3,X-Y+2/3,Z+2/3
REMARK 290 15555 -X+Y+1/3,-X+2/3,Z+2/3
REMARK 290 16555 Y+1/3,X+2/3,-Z+2/3
REMARK 290 17555 X-Y+1/3,-Y+2/3,-Z+2/3
REMARK 290 18555 -X+1/3,-X+Y+2/3,-Z+2/3
REMARK 290
REMARK 290 WHERE NNN -> OPERATOR NUMBER
REMARK 290 MMM -> TRANSLATION VECTOR
REMARK 290
REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS
REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM
REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY
REMARK 290 RELATED MOLECULES.
REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000
REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000
REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000
REMARK 290 SMTRY1 2 -0.500000 -0.866025 0.000000 0.00000
REMARK 290 SMTRY2 2 0.866025 -0.500000 0.000000 0.00000
REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 0.00000
REMARK 290 SMTRY1 3 -0.500000 0.866025 0.000000 0.00000
REMARK 290 SMTRY2 3 -0.866025 -0.500000 0.000000 0.00000
REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 0.00000
REMARK 290 SMTRY1 4 -0.500000 0.866025 0.000000 0.00000
REMARK 290 SMTRY2 4 0.866025 0.500000 0.000000 0.00000
REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000
REMARK 290 SMTRY1 5 1.000000 0.000000 0.000000 0.00000
REMARK 290 SMTRY2 5 0.000000 -1.000000 0.000000 0.00000
REMARK 290 SMTRY3 5 0.000000 0.000000 -1.000000 0.00000
REMARK 290 SMTRY1 6 -0.500000 -0.866025 0.000000 0.00000
REMARK 290 SMTRY2 6 -0.866025 0.500000 0.000000 0.00000
REMARK 290 SMTRY3 6 0.000000 0.000000 -1.000000 0.00000
REMARK 290 SMTRY1 7 1.000000 0.000000 0.000000 112.13550
REMARK 290 SMTRY2 7 0.000000 1.000000 0.000000 64.74146
REMARK 290 SMTRY3 7 0.000000 0.000000 1.000000 25.06833
REMARK 290 SMTRY1 8 -0.500000 -0.866025 0.000000 112.13550
REMARK 290 SMTRY2 8 0.866025 -0.500000 0.000000 64.74146
REMARK 290 SMTRY3 8 0.000000 0.000000 1.000000 25.06833
REMARK 290 SMTRY1 9 -0.500000 0.866025 0.000000 112.13550
REMARK 290 SMTRY2 9 -0.866025 -0.500000 0.000000 64.74146
REMARK 290 SMTRY3 9 0.000000 0.000000 1.000000 25.06833
REMARK 290 SMTRY1 10 -0.500000 0.866025 0.000000 112.13550
REMARK 290 SMTRY2 10 0.866025 0.500000 0.000000 64.74146
REMARK 290 SMTRY3 10 0.000000 0.000000 -1.000000 25.06833
REMARK 290 SMTRY1 11 1.000000 0.000000 0.000000 112.13550
REMARK 290 SMTRY2 11 0.000000 -1.000000 0.000000 64.74146
REMARK 290 SMTRY3 11 0.000000 0.000000 -1.000000 25.06833
REMARK 290 SMTRY1 12 -0.500000 -0.866025 0.000000 112.13550
REMARK 290 SMTRY2 12 -0.866025 0.500000 0.000000 64.74146
REMARK 290 SMTRY3 12 0.000000 0.000000 -1.000000 25.06833
REMARK 290 SMTRY1 13 1.000000 0.000000 0.000000 0.00000
REMARK 290 SMTRY2 13 0.000000 1.000000 0.000000 129.48292
REMARK 290 SMTRY3 13 0.000000 0.000000 1.000000 50.13667
REMARK 290 SMTRY1 14 -0.500000 -0.866025 0.000000 0.00000
REMARK 290 SMTRY2 14 0.866025 -0.500000 0.000000 129.48292
REMARK 290 SMTRY3 14 0.000000 0.000000 1.000000 50.13667
REMARK 290 SMTRY1 15 -0.500000 0.866025 0.000000 0.00000
REMARK 290 SMTRY2 15 -0.866025 -0.500000 0.000000 129.48292
REMARK 290 SMTRY3 15 0.000000 0.000000 1.000000 50.13667
REMARK 290 SMTRY1 16 -0.500000 0.866025 0.000000 0.00000
REMARK 290 SMTRY2 16 0.866025 0.500000 0.000000 129.48292
REMARK 290 SMTRY3 16 0.000000 0.000000 -1.000000 50.13667
REMARK 290 SMTRY1 17 1.000000 0.000000 0.000000 0.00000
REMARK 290 SMTRY2 17 0.000000 -1.000000 0.000000 129.48292
REMARK 290 SMTRY3 17 0.000000 0.000000 -1.000000 50.13667
REMARK 290 SMTRY1 18 -0.500000 -0.866025 0.000000 0.00000
REMARK 290 SMTRY2 18 -0.866025 0.500000 0.000000 129.48292
REMARK 290 SMTRY3 18 0.000000 0.000000 -1.000000 50.13667
REMARK 290
REMARK 290 REMARK: NULL
REMARK 300
REMARK 300 BIOMOLECULE: 1
REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM
REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN
REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON
REMARK 300 BURIED SURFACE AREA.
REMARK 350
REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN
REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE
REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS
REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND
REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN.
REMARK 350
REMARK 350 BIOMOLECULE: 1
REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: TETRAMERIC
REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: TETRAMERIC
REMARK 350 SOFTWARE USED: PISA,PQS
REMARK 350 TOTAL BURIED SURFACE AREA: 7830 ANGSTROM**2
REMARK 350 SURFACE AREA OF THE COMPLEX: 15660 ANGSTROM**2
REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -125.0 KCAL/MOL
REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B, C, D
REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000
REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000
REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000
REMARK 465
REMARK 465 MISSING RESIDUES
REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE
REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN
REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.)
REMARK 465
REMARK 465 M RES C SSSEQI
REMARK 465 MET A -10
REMARK 465 ALA A -9
REMARK 465 SER A -8
REMARK 465 MET A -7
REMARK 465 THR A -6
REMARK 465 GLY A -5
REMARK 465 GLY A -4
REMARK 465 GLN A -3
REMARK 465 GLN A -2
REMARK 465 SER A 183
REMARK 465 HIS A 184
REMARK 465 HIS A 185
REMARK 465 HIS A 186
REMARK 465 HIS A 187
REMARK 465 HIS A 188
REMARK 465 HIS A 189
REMARK 465 MET C -10
REMARK 465 ALA C -9
REMARK 465 SER C -8
REMARK 465 MET C -7
REMARK 465 THR C -6
REMARK 465 GLY C -5
REMARK 465 GLY C -4
REMARK 465 GLN C -3
REMARK 465 GLN C -2
REMARK 465 MET C -1
REMARK 465 GLY C 0
REMARK 465 ALA C 1
REMARK 465 PRO C 2
REMARK 465 ILE C 3
REMARK 465 THR C 4
REMARK 465 ALA C 5
REMARK 465 TYR C 6
REMARK 465 ALA C 7
REMARK 465 GLN C 8
REMARK 465 GLN C 9
REMARK 465 THR C 10
REMARK 465 ARG C 11
REMARK 465 GLY C 12
REMARK 465 LEU C 13
REMARK 465 LEU C 14
REMARK 465 GLY C 15
REMARK 465 CYS C 16
REMARK 465 ILE C 17
REMARK 465 ILE C 18
REMARK 465 THR C 19
REMARK 465 SER C 20
REMARK 465 LEU C 21
REMARK 465 THR C 22
REMARK 465 GLY C 23
REMARK 465 ARG C 24
REMARK 465 ASP C 25
REMARK 465 LYS C 26
REMARK 465 ASN C 27
REMARK 465 GLN C 28
REMARK 465 ARG C 180
REMARK 465 SER C 181
REMARK 465 GLY C 182
REMARK 465 SER C 183
REMARK 465 HIS C 184
REMARK 465 HIS C 185
REMARK 465 HIS C 186
REMARK 465 HIS C 187
REMARK 465 HIS C 188
REMARK 465 HIS C 189
REMARK 465 LYS D 19
REMARK 465 ILE D 37
REMARK 465 ILE D 38
REMARK 465 PRO D 39
REMARK 465 LYS D 40
REMARK 465 LYS D 41
REMARK 500
REMARK 500 GEOMETRY AND STEREOCHEMISTRY
REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT
REMARK 500
REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT.
REMARK 500
REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE
REMARK 500 ZN ZN A 901 O HOH A 1000 1.54
REMARK 500
REMARK 500 REMARK: NULL
REMARK 500
REMARK 500 GEOMETRY AND STEREOCHEMISTRY
REMARK 500 SUBTOPIC: TORSION ANGLES
REMARK 500
REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS:
REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER;
REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE).
REMARK 500
REMARK 500 STANDARD TABLE:
REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2)
REMARK 500
REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI-
REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400
REMARK 500
REMARK 500 M RES CSSEQI PSI PHI
REMARK 500 ALA A 1 56.27 79.75
REMARK 500 PHE A 43 -156.11 -156.05
REMARK 500 ASN A 49 50.59 39.65
REMARK 500 HIS A 57 24.93 -69.68
REMARK 500 LYS A 68 34.77 -84.96
REMARK 500 CYS A 99 -0.74 -166.27
REMARK 500 SER A 122 26.91 -140.36
REMARK 500 PRO A 146 -7.86 -56.29
REMARK 500 ARG A 161 11.89 52.57
REMARK 500 ASP C 121 0.85 -64.48
REMARK 500 SER C 122 21.32 -153.88
REMARK 500
REMARK 500 REMARK: NULL
REMARK 500
REMARK 500 GEOMETRY AND STEREOCHEMISTRY
REMARK 500 SUBTOPIC: PLANAR GROUPS
REMARK 500
REMARK 500 PLANAR GROUPS IN THE FOLLOWING RESIDUES HAVE A TOTAL
REMARK 500 RMS DISTANCE OF ALL ATOMS FROM THE BEST-FIT PLANE
REMARK 500 BY MORE THAN AN EXPECTED VALUE OF 6*RMSD, WITH AN
REMARK 500 RMSD 0.02 ANGSTROMS, OR AT LEAST ONE ATOM HAS
REMARK 500 AN RMSD GREATER THAN THIS VALUE
REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER;
REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE).
REMARK 500
REMARK 500 M RES CSSEQI RMS TYPE
REMARK 500 TYR A 105 0.07 SIDE CHAIN
REMARK 500
REMARK 500 REMARK: NULL
REMARK 600
REMARK 600 HETEROGEN
REMARK 600
REMARK 600 UPON BINDING TO SER A139 THE ALDEHYDE GROUP OF THE STARTING
REMARK 600 MOLECULE HUD FORMS A HEMIACETAL BONDING WITH THE PROTEIN
REMARK 620
REMARK 620 METAL COORDINATION
REMARK 620 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER;
REMARK 620 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE):
REMARK 620
REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL
REMARK 620 ZN A 901 ZN
REMARK 620 N RES CSSEQI ATOM
REMARK 620 1 CYS A 97 SG
REMARK 620 2 CYS A 99 SG 95.5
REMARK 620 3 CYS A 145 SG 91.4 110.4
REMARK 620 N 1 2
REMARK 620
REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL
REMARK 620 ZN C 201 ZN
REMARK 620 N RES CSSEQI ATOM
REMARK 620 1 CYS C 97 SG
REMARK 620 2 CYS C 99 SG 87.2
REMARK 620 3 CYS C 145 SG 91.4 107.1
REMARK 620 4 HOH C 301 O 111.2 120.2 127.6
REMARK 620 N 1 2 3
REMARK 630
REMARK 630 MOLECULE TYPE: PEPTIDE-LIKE INHIBITOR
REMARK 630 MOLECULE NAME: TERT-BUTYL {(2S)-1-[(1R,2S,5S)-2-{[(2S,3R)-4-AMINO-
REMARK 630 1-CYCLOPROPYL-3-HYDROXY-4-OXOBUTAN-2-YL]CARBAMOYL}-6,6-DIMETHYL-3-
REMARK 630 AZABICYCLO[3.1.0]HEX-3-YL]-3,3-DIMETHYL-1-OXOBUTAN-2-YL}CARBAMATE
REMARK 630 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER;
REMARK 630 SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.)
REMARK 630
REMARK 630 M RES C SSSEQI
REMARK 630 HUD A 903
REMARK 630 SOURCE: NULL
REMARK 630 TAXONOMY: NULL
REMARK 630 SUBCOMP: BOC TBG 12L 1E1
REMARK 630 DETAILS: NULL
REMARK 800
REMARK 800 SITE
REMARK 800 SITE_IDENTIFIER: AC1
REMARK 800 EVIDENCE_CODE: SOFTWARE
REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE ZN A 901
REMARK 800
REMARK 800 SITE_IDENTIFIER: AC2
REMARK 800 EVIDENCE_CODE: SOFTWARE
REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE BME A 902
REMARK 800
REMARK 800 SITE_IDENTIFIER: AC3
REMARK 800 EVIDENCE_CODE: SOFTWARE
REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE HUD A 903
REMARK 800
REMARK 800 SITE_IDENTIFIER: AC4
REMARK 800 EVIDENCE_CODE: SOFTWARE
REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE ZN C 201
REMARK 900
REMARK 900 RELATED ENTRIES
REMARK 900 RELATED ID: 1A1R RELATED DB: PDB
REMARK 900 CRYSTAL STRUCTURE OF THE HEPATITIS C VIRUS NS3 PROTEASE DOMAIN
REMARK 900 COMPLEXED WITH A SYNTHETIC NS4A COFACTOR PEPTIDE.
REMARK 900 RELATED ID: 2A4G RELATED DB: PDB
REMARK 900 HEPATITIS C VIRUS NS3-4A SERINE PROTEASE INHIBITORS. SAR OF P2'
REMARK 900 MOIETY WITH IMPROVED POTENCY.
REMARK 900 RELATED ID: 2A4Q RELATED DB: PDB
REMARK 900 SYNTHESIS AND BIOLOGICAL ACTIVITY OF MACROCYCLIC INHIBITORS OF
REMARK 900 HEPATITIS C VIRUS (HCV) NS3 PROTEASE
REMARK 900 RELATED ID: 2A4R RELATED DB: PDB
REMARK 900 HEPATITIS C VIRUS NS3-4A SERINE PROTEASE INHIBITORS: USE OF A P2-P1
REMARK 900 CYCLOPROPYL ALANINE COMBINATION FOR IMPROVED POTENCY.
REMARK 900 RELATED ID: 2FM2 RELATED DB: PDB
REMARK 900 MUTATIONS CONFERRING RESISTANCE TO SCH6, A NOVEL HEPATITIS C VIRUS
REMARK 900 NS3/4A PROTEASE INHIBITOR REDUCED RNA REPLICATION FITNESS AND
REMARK 900 PARTIAL RESCUE BY SECOND SITE MUTATIONS
REMARK 900 RELATED ID: 2F9V RELATED DB: PDB
REMARK 900 DEPEPTIDIZATION EFFORTS ON P3-P2 A-KETOAMIDE INHIBITORS OF HCV NS3-
REMARK 900 4A SERINE PROTEASE: EFFECT ON HCV REPLICON ACTIVITY.
DBREF 2OBO A 1 181 UNP Q91RS4 Q91RS4_9HEPC 1 181
DBREF 2OBO B 21 39 UNP Q9QP06 Q9QP06_9HEPC 1678 1696
DBREF 2OBO C 1 181 UNP Q91RS4 Q91RS4_9HEPC 1 181
DBREF 2OBO D 21 39 UNP Q9QP06 Q9QP06_9HEPC 1678 1696
SEQADV 2OBO MET A -10 UNP Q91RS4 EXPRESSION TAG
SEQADV 2OBO ALA A -9 UNP Q91RS4 EXPRESSION TAG
SEQADV 2OBO SER A -8 UNP Q91RS4 EXPRESSION TAG
SEQADV 2OBO MET A -7 UNP Q91RS4 EXPRESSION TAG
SEQADV 2OBO THR A -6 UNP Q91RS4 EXPRESSION TAG
SEQADV 2OBO GLY A -5 UNP Q91RS4 EXPRESSION TAG
SEQADV 2OBO GLY A -4 UNP Q91RS4 EXPRESSION TAG
SEQADV 2OBO GLN A -3 UNP Q91RS4 EXPRESSION TAG
SEQADV 2OBO GLN A -2 UNP Q91RS4 EXPRESSION TAG
SEQADV 2OBO MET A -1 UNP Q91RS4 EXPRESSION TAG
SEQADV 2OBO GLY A 0 UNP Q91RS4 EXPRESSION TAG
SEQADV 2OBO THR A 40 UNP Q91RS4 ALA 40 CONFLICT
SEQADV 2OBO SER A 91 UNP Q91RS4 ALA 91 CONFLICT
SEQADV 2OBO GLY A 182 UNP Q91RS4 EXPRESSION TAG
SEQADV 2OBO SER A 183 UNP Q91RS4 EXPRESSION TAG
SEQADV 2OBO HIS A 184 UNP Q91RS4 EXPRESSION TAG
SEQADV 2OBO HIS A 185 UNP Q91RS4 EXPRESSION TAG
SEQADV 2OBO HIS A 186 UNP Q91RS4 EXPRESSION TAG
SEQADV 2OBO HIS A 187 UNP Q91RS4 EXPRESSION TAG
SEQADV 2OBO HIS A 188 UNP Q91RS4 EXPRESSION TAG
SEQADV 2OBO HIS A 189 UNP Q91RS4 EXPRESSION TAG
SEQADV 2OBO LYS B 19 UNP Q9QP06 EXPRESSION TAG
SEQADV 2OBO LYS B 20 UNP Q9QP06 EXPRESSION TAG
SEQADV 2OBO LYS B 40 UNP Q9QP06 EXPRESSION TAG
SEQADV 2OBO LYS B 41 UNP Q9QP06 EXPRESSION TAG
SEQADV 2OBO MET C -10 UNP Q91RS4 EXPRESSION TAG
SEQADV 2OBO ALA C -9 UNP Q91RS4 EXPRESSION TAG
SEQADV 2OBO SER C -8 UNP Q91RS4 EXPRESSION TAG
SEQADV 2OBO MET C -7 UNP Q91RS4 EXPRESSION TAG
SEQADV 2OBO THR C -6 UNP Q91RS4 EXPRESSION TAG
SEQADV 2OBO GLY C -5 UNP Q91RS4 EXPRESSION TAG
SEQADV 2OBO GLY C -4 UNP Q91RS4 EXPRESSION TAG
SEQADV 2OBO GLN C -3 UNP Q91RS4 EXPRESSION TAG
SEQADV 2OBO GLN C -2 UNP Q91RS4 EXPRESSION TAG
SEQADV 2OBO MET C -1 UNP Q91RS4 EXPRESSION TAG
SEQADV 2OBO GLY C 0 UNP Q91RS4 EXPRESSION TAG
SEQADV 2OBO THR C 40 UNP Q91RS4 ALA 40 CONFLICT
SEQADV 2OBO SER C 91 UNP Q91RS4 ALA 91 CONFLICT
SEQADV 2OBO GLY C 182 UNP Q91RS4 EXPRESSION TAG
SEQADV 2OBO SER C 183 UNP Q91RS4 EXPRESSION TAG
SEQADV 2OBO HIS C 184 UNP Q91RS4 EXPRESSION TAG
SEQADV 2OBO HIS C 185 UNP Q91RS4 EXPRESSION TAG
SEQADV 2OBO HIS C 186 UNP Q91RS4 EXPRESSION TAG
SEQADV 2OBO HIS C 187 UNP Q91RS4 EXPRESSION TAG
SEQADV 2OBO HIS C 188 UNP Q91RS4 EXPRESSION TAG
SEQADV 2OBO HIS C 189 UNP Q91RS4 EXPRESSION TAG
SEQADV 2OBO LYS D 19 UNP Q9QP06 EXPRESSION TAG
SEQADV 2OBO LYS D 20 UNP Q9QP06 EXPRESSION TAG
SEQADV 2OBO LYS D 40 UNP Q9QP06 EXPRESSION TAG
SEQADV 2OBO LYS D 41 UNP Q9QP06 EXPRESSION TAG
SEQRES 1 A 200 MET ALA SER MET THR GLY GLY GLN GLN MET GLY ALA PRO
SEQRES 2 A 200 ILE THR ALA TYR ALA GLN GLN THR ARG GLY LEU LEU GLY
SEQRES 3 A 200 CYS ILE ILE THR SER LEU THR GLY ARG ASP LYS ASN GLN
SEQRES 4 A 200 VAL GLU GLY GLU VAL GLN ILE VAL SER THR ALA THR GLN
SEQRES 5 A 200 THR PHE LEU ALA THR CYS ILE ASN GLY VAL CYS TRP THR
SEQRES 6 A 200 VAL TYR HIS GLY ALA GLY THR ARG THR ILE ALA SER PRO
SEQRES 7 A 200 LYS GLY PRO VAL ILE GLN MET TYR THR ASN VAL ASP GLN
SEQRES 8 A 200 ASP LEU VAL GLY TRP PRO ALA PRO GLN GLY SER ARG SER
SEQRES 9 A 200 LEU THR PRO CYS THR CYS GLY SER SER ASP LEU TYR LEU
SEQRES 10 A 200 VAL THR ARG HIS ALA ASP VAL ILE PRO VAL ARG ARG ARG
SEQRES 11 A 200 GLY ASP SER ARG GLY SER LEU LEU SER PRO ARG PRO ILE
SEQRES 12 A 200 SER TYR LEU LYS GLY SER SER GLY GLY PRO LEU LEU CYS
SEQRES 13 A 200 PRO ALA GLY HIS ALA VAL GLY LEU PHE ARG ALA ALA VAL
SEQRES 14 A 200 CYS THR ARG GLY VAL ALA LYS ALA VAL ASP PHE ILE PRO
SEQRES 15 A 200 VAL GLU ASN LEU GLU THR THR MET ARG SER GLY SER HIS
SEQRES 16 A 200 HIS HIS HIS HIS HIS
SEQRES 1 B 23 LYS LYS GLY SER VAL VAL ILE VAL GLY ARG ILE VAL LEU
SEQRES 2 B 23 SER GLY LYS PRO ALA ILE ILE PRO LYS LYS
SEQRES 1 C 200 MET ALA SER MET THR GLY GLY GLN GLN MET GLY ALA PRO
SEQRES 2 C 200 ILE THR ALA TYR ALA GLN GLN THR ARG GLY LEU LEU GLY
SEQRES 3 C 200 CYS ILE ILE THR SER LEU THR GLY ARG ASP LYS ASN GLN
SEQRES 4 C 200 VAL GLU GLY GLU VAL GLN ILE VAL SER THR ALA THR GLN
SEQRES 5 C 200 THR PHE LEU ALA THR CYS ILE ASN GLY VAL CYS TRP THR
SEQRES 6 C 200 VAL TYR HIS GLY ALA GLY THR ARG THR ILE ALA SER PRO
SEQRES 7 C 200 LYS GLY PRO VAL ILE GLN MET TYR THR ASN VAL ASP GLN
SEQRES 8 C 200 ASP LEU VAL GLY TRP PRO ALA PRO GLN GLY SER ARG SER
SEQRES 9 C 200 LEU THR PRO CYS THR CYS GLY SER SER ASP LEU TYR LEU
SEQRES 10 C 200 VAL THR ARG HIS ALA ASP VAL ILE PRO VAL ARG ARG ARG
SEQRES 11 C 200 GLY ASP SER ARG GLY SER LEU LEU SER PRO ARG PRO ILE
SEQRES 12 C 200 SER TYR LEU LYS GLY SER SER GLY GLY PRO LEU LEU CYS
SEQRES 13 C 200 PRO ALA GLY HIS ALA VAL GLY LEU PHE ARG ALA ALA VAL
SEQRES 14 C 200 CYS THR ARG GLY VAL ALA LYS ALA VAL ASP PHE ILE PRO
SEQRES 15 C 200 VAL GLU ASN LEU GLU THR THR MET ARG SER GLY SER HIS
SEQRES 16 C 200 HIS HIS HIS HIS HIS
SEQRES 1 D 23 LYS LYS GLY SER VAL VAL ILE VAL GLY ARG ILE VAL LEU
SEQRES 2 D 23 SER GLY LYS PRO ALA ILE ILE PRO LYS LYS
HET ZN A 901 1
HET BME A 902 4
HET HUD A 903 36
HET ZN C 201 1
HETNAM ZN ZINC ION
HETNAM BME BETA-MERCAPTOETHANOL
HETNAM HUD TERT-BUTYL {(2S)-1-[(1R,2S,5S)-2-{[(2S,3R)-4-AMINO-1-
HETNAM 2 HUD CYCLOPROPYL-3-HYDROXY-4-OXOBUTAN-2-YL]CARBAMOYL}-6,6-
HETNAM 3 HUD DIMETHYL-3-AZABICYCLO[3.1.0]HEX-3-YL]-3,3-DIMETHYL-1-
HETNAM 4 HUD OXOBUTAN-2-YL}CARBAMATE
HETSYN HUD KETOAMIDE INHIBITOR SCH476776, BOUND FORM
FORMUL 5 ZN 2(ZN 2+)
FORMUL 6 BME C2 H6 O S
FORMUL 7 HUD C26 H44 N4 O6
FORMUL 9 HOH *135(H2 O)
HELIX 1 1 GLY A 12 GLY A 23 1 12
HELIX 2 2 TYR A 56 GLY A 60 1 5
HELIX 3 3 ILE A 132 LYS A 136 1 5
HELIX 4 4 VAL A 172 GLY A 182 1 11
HELIX 5 5 TYR C 56 GLY C 60 1 5
HELIX 6 6 ILE C 132 LYS C 136 1 5
HELIX 7 7 VAL C 172 THR C 178 1 7
SHEET 1 A 7 TYR A 6 GLN A 9 0
SHEET 2 A 7 VAL B 24 VAL B 30 -1 O VAL B 30 N TYR A 6
SHEET 3 A 7 VAL A 33 SER A 37 -1 N ILE A 35 O VAL B 26
SHEET 4 A 7 THR A 42 ILE A 48 -1 O PHE A 43 N VAL A 36
SHEET 5 A 7 VAL A 51 VAL A 55 -1 O TRP A 53 N THR A 46
SHEET 6 A 7 LEU A 82 PRO A 86 -1 O TRP A 85 N CYS A 52
SHEET 7 A 7 TYR A 75 ASN A 77 -1 N ASN A 77 O LEU A 82
SHEET 1 B 2 ILE A 64 SER A 66 0
SHEET 2 B 2 GLY A 69 VAL A 71 -1 O VAL A 71 N ILE A 64
SHEET 1 C 7 ASP A 103 VAL A 107 0
SHEET 2 C 7 VAL A 113 GLY A 120 -1 O VAL A 116 N LEU A 104
SHEET 3 C 7 ARG A 123 PRO A 131 -1 O ARG A 123 N ARG A 119
SHEET 4 C 7 VAL A 163 PRO A 171 -1 O ALA A 164 N ARG A 130
SHEET 5 C 7 ALA A 150 THR A 160 -1 N VAL A 158 O ALA A 166
SHEET 6 C 7 PRO A 142 LEU A 144 -1 N LEU A 143 O VAL A 151
SHEET 7 C 7 ASP A 103 VAL A 107 -1 N TYR A 105 O LEU A 144
SHEET 1 D 3 ALA B 36 ILE B 38 0
SHEET 2 D 3 SER D 22 VAL D 30 -1 O VAL D 30 N ALA B 36
SHEET 3 D 3 THR C 63 ILE C 64 1 N THR C 63 O VAL D 23
SHEET 1 E 7 ALA B 36 ILE B 38 0
SHEET 2 E 7 SER D 22 VAL D 30 -1 O VAL D 30 N ALA B 36
SHEET 3 E 7 VAL C 33 SER C 37 -1 N ILE C 35 O VAL D 26
SHEET 4 E 7 THR C 42 ILE C 48 -1 O PHE C 43 N VAL C 36
SHEET 5 E 7 VAL C 51 VAL C 55 -1 O VAL C 51 N ILE C 48
SHEET 6 E 7 LEU C 82 PRO C 86 -1 O TRP C 85 N CYS C 52
SHEET 7 E 7 TYR C 75 ASN C 77 -1 N ASN C 77 O LEU C 82
SHEET 1 F 8 ARG C 130 PRO C 131 0
SHEET 2 F 8 VAL C 163 PRO C 171 -1 O ALA C 164 N ARG C 130
SHEET 3 F 8 ALA C 150 THR C 160 -1 N ALA C 156 O ASP C 168
SHEET 4 F 8 PRO C 142 LEU C 144 -1 N LEU C 143 O VAL C 151
SHEET 5 F 8 ASP C 103 VAL C 107 -1 N TYR C 105 O LEU C 144
SHEET 6 F 8 VAL C 113 GLY C 120 -1 O ILE C 114 N LEU C 106
SHEET 7 F 8 ARG C 123 LEU C 126 -1 O SER C 125 N ARG C 117
SHEET 8 F 8 VAL C 163 PRO C 171 -1 O VAL C 167 N GLY C 124
SSBOND 1 CYS C 97 CYS C 99 1555 1555 2.99
LINK SG CYS A 16 S2 BME A 902 1555 1555 2.04
LINK OG SER A 139 C33 HUD A 903 1555 1555 1.46
LINK SG CYS A 97 ZN ZN A 901 1555 1555 1.93
LINK SG CYS A 99 ZN ZN A 901 1555 1555 2.45
LINK SG CYS A 145 ZN ZN A 901 1555 1555 2.28
LINK SG CYS C 97 ZN ZN C 201 1555 1555 2.14
LINK SG CYS C 99 ZN ZN C 201 1555 1555 2.20
LINK SG CYS C 145 ZN ZN C 201 1555 1555 2.07
LINK ZN ZN C 201 O HOH C 301 1555 1555 1.87
CISPEP 1 ALA A 1 PRO A 2 0 -0.01
SITE 1 AC1 5 CYS A 97 THR A 98 CYS A 99 CYS A 145
SITE 2 AC1 5 HOH A1000
SITE 1 AC2 4 LEU A 13 CYS A 16 ILE A 17 THR A 38
SITE 1 AC3 10 GLN A 41 HIS A 57 LYS A 136 GLY A 137
SITE 2 AC3 10 SER A 138 SER A 139 ARG A 155 ALA A 156
SITE 3 AC3 10 ALA A 157 ASP A 168
SITE 1 AC4 4 CYS C 97 CYS C 99 CYS C 145 HOH C 301
CRYST1 224.271 224.271 75.205 90.00 90.00 120.00 H 3 2 36
ORIGX1 1.000000 0.000000 0.000000 0.00000
ORIGX2 0.000000 1.000000 0.000000 0.00000
ORIGX3 0.000000 0.000000 1.000000 0.00000
SCALE1 0.004459 0.002574 0.000000 0.00000
SCALE2 0.000000 0.005149 0.000000 0.00000
SCALE3 0.000000 0.000000 0.013297 0.00000